HomeELIC • STO
add
Elicera Therapeutics AB
Previous close
kr 5.40
Day range
kr 5.40 - kr 5.63
Year range
kr 1.65 - kr 8.43
Market cap
271.31M SEK
Avg Volume
112.01K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 7.91M | 3,285.70% |
Operating expense | 7.76M | 164.88% |
Net income | 304.15K | 112.10% |
Net profit margin | 3.85 | 100.36% |
Earnings per share | — | — |
EBITDA | 149.63K | 105.55% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 34.92M | 14.01% |
Total assets | 37.30M | 19.88% |
Total liabilities | 6.97M | -9.94% |
Total equity | 30.33M | — |
Shares outstanding | 48.54M | — |
Price to book | 8.71 | — |
Return on assets | 0.94% | — |
Return on capital | 1.22% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 304.15K | 112.10% |
Cash from operations | -4.74M | -112.15% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -4.74M | -112.15% |
Free cash flow | -4.95M | -251.31% |
About
Founded
2014
Website
Employees
2
